Fragile X Syndrome Market Report

Europe Fragile X Syndrome Market Size, Status and Forecast 2014-2026

  • POSTDATE：Jan 31, 2020
  • PAGES：156
  • REPORT CODE：GMM455190
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Fragile X Syndrome market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.4% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Fragile X Syndrome Market Segmentations:

    By Player:

    • Sage Therapeutics, Inc

    • Aelis Farma SAS

    • Confluence Pharmaceuticals LLC

    • Neuren Pharmaceuticals Limited

    • F Hoffmann-La Roche Ltd

    • Marinus Pharmaceuticals, Inc.

    • Ovid Therapeutics Inc

    • F. Hoffmann-La Roche Ltd.

    • MI.TO. Technology S.r.L.

    • Zynerba Pharmaceuticals, Inc.

    • AMO Pharma Limited.

    • MITO Technology SrL.

    By Type:

    • ACT-01

    • AMO-01

    • ANAVEX-273

    • AUT-00206

    • Bryostatin-1

    • Cannabidiol

    • Others

    By End-User:

    • Clinic

    • Hopital

    • Research Center

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Fragile X Syndrome Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Fragile X Syndrome Market Size and Growth Rate of ACT-01 from 2014 to 2026

    • 1.3.2 Europe Fragile X Syndrome Market Size and Growth Rate of AMO-01 from 2014 to 2026

    • 1.3.3 Europe Fragile X Syndrome Market Size and Growth Rate of ANAVEX-273 from 2014 to 2026

    • 1.3.4 Europe Fragile X Syndrome Market Size and Growth Rate of AUT-00206 from 2014 to 2026

    • 1.3.5 Europe Fragile X Syndrome Market Size and Growth Rate of Bryostatin-1 from 2014 to 2026

    • 1.3.6 Europe Fragile X Syndrome Market Size and Growth Rate of Cannabidiol from 2014 to 2026

    • 1.3.7 Europe Fragile X Syndrome Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Fragile X Syndrome Market Size and Growth Rate of Clinic from 2014 to 2026

    • 1.4.2 Europe Fragile X Syndrome Market Size and Growth Rate of Hopital from 2014 to 2026

    • 1.4.3 Europe Fragile X Syndrome Market Size and Growth Rate of Research Center from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Fragile X Syndrome Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Fragile X Syndrome Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Fragile X Syndrome Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Fragile X Syndrome Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Fragile X Syndrome Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Fragile X Syndrome Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Fragile X Syndrome Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Fragile X Syndrome Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Fragile X Syndrome Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Fragile X Syndrome Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Fragile X Syndrome Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Fragile X Syndrome Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Fragile X Syndrome Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Fragile X Syndrome by Major Types

      • 3.4.1 Market Size and Growth Rate of ACT-01

      • 3.4.2 Market Size and Growth Rate of AMO-01

      • 3.4.3 Market Size and Growth Rate of ANAVEX-273

      • 3.4.4 Market Size and Growth Rate of AUT-00206

      • 3.4.5 Market Size and Growth Rate of Bryostatin-1

      • 3.4.6 Market Size and Growth Rate of Cannabidiol

      • 3.4.7 Market Size and Growth Rate of Others

    4 Segmentation of Fragile X Syndrome Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Fragile X Syndrome by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Fragile X Syndrome for Clinic

      • 4.4.2 Market Size and Growth Rate of Fragile X Syndrome for Hopital

      • 4.4.3 Market Size and Growth Rate of Fragile X Syndrome for Research Center

    5 Market Analysis by Major Regions

    • 5.1 Europe Fragile X Syndrome Production Analysis by Top Regions

    • 5.2 Europe Fragile X Syndrome Consumption Analysis by Top Regions

    • 5.3 Europe Fragile X Syndrome Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Fragile X Syndrome Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Fragile X Syndrome Production, Import, Consumption and Export Analysis

      • 5.3.3 France Fragile X Syndrome Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Fragile X Syndrome Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Fragile X Syndrome Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Fragile X Syndrome Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Fragile X Syndrome Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Fragile X Syndrome Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Fragile X Syndrome Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Fragile X Syndrome Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Fragile X Syndrome Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Fragile X Syndrome Production, Import, Consumption and Export Analysis

    6 Product Circulation of Fragile X Syndrome Market among Top Countries

    • 6.1 Top 5 Export Countries in Fragile X Syndrome Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Fragile X Syndrome Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Fragile X Syndrome Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Fragile X Syndrome Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Fragile X Syndrome Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Fragile X Syndrome Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Fragile X Syndrome Landscape Analysis

    • 7.1 Germany Fragile X Syndrome Landscape Analysis by Major Types

    • 7.2 Germany Fragile X Syndrome Landscape Analysis by Major End-Users

    8. UK Fragile X Syndrome Landscape Analysis

    • 8.1 UK Fragile X Syndrome Landscape Analysis by Major Types

    • 8.2 UK Fragile X Syndrome Landscape Analysis by Major End-Users

    9. France Fragile X Syndrome Landscape Analysis

    • 9.1 France Fragile X Syndrome Landscape Analysis by Major Types

    • 9.2 France Fragile X Syndrome Landscape Analysis by Major End-Users

    10. Italy Fragile X Syndrome Landscape Analysis

    • 10.1 Italy Fragile X Syndrome Landscape Analysis by Major Types

    • 10.2 Italy Fragile X Syndrome Landscape Analysis by Major End-Users

    11. Spain Fragile X Syndrome Landscape Analysis

    • 11.1 Spain Fragile X Syndrome Landscape Analysis by Major Types

    • 11.2 Spain Fragile X Syndrome Landscape Analysis by Major End-Users

    12. Poland Fragile X Syndrome Landscape Analysis

    • 12.1 Poland Fragile X Syndrome Landscape Analysis by Major Types

    • 12.2 Poland Fragile X Syndrome Landscape Analysis by Major End-Users

    13. Russia Fragile X Syndrome Landscape Analysis

    • 13.1 Russia Fragile X Syndrome Landscape Analysis by Major Types

    • 13.2 Russia Fragile X Syndrome Landscape Analysis by Major End-Users

    14. Switzerland Fragile X Syndrome Landscape Analysis

    • 14.1 Switzerland Fragile X Syndrome Landscape Analysis by Major Types

    • 14.2 Switzerland Fragile X Syndrome Landscape Analysis by Major End-Users

    15. Turkey Fragile X Syndrome Landscape Analysis

    • 15.1 Turkey Fragile X Syndrome Landscape Analysis by Major Types

    • 15.2 Turkey Fragile X Syndrome Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Fragile X Syndrome Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Fragile X Syndrome Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Fragile X Syndrome Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Fragile X Syndrome Landscape Analysis by Top Countries

      • 16.3.1 Denmark Fragile X Syndrome Market Volume and Growth Rate

      • 16.3.2 Finland Fragile X Syndrome Market Volume and Growth Rate

      • 16.3.3 Norway Fragile X Syndrome Market Volume and Growth Rate

      • 16.3.4 Sweden Fragile X Syndrome Market Volume and Growth Rate

      • 16.3.6 Iceland Fragile X Syndrome Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Fragile X Syndrome Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Fragile X Syndrome Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Fragile X Syndrome Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Fragile X Syndrome Landscape Analysis by Top Countries

      • 17.3.1 Belgium Fragile X Syndrome Market Volume and Growth Rate

      • 17.3.2 Netherlands Fragile X Syndrome Market Volume and Growth Rate

      • 17.3.3 Luxembourg Fragile X Syndrome Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Fragile X Syndrome Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Fragile X Syndrome Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Fragile X Syndrome Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Fragile X Syndrome Landscape Analysis by Top Countries

      • 18.3.1 Estonia Fragile X Syndrome Market Volume and Growth Rate

      • 18.3.2 Latvia Fragile X Syndrome Market Volume and Growth Rate

      • 18.3.3 Lithuania Fragile X Syndrome Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Sage Therapeutics, Inc

      • 19.1.1 Sage Therapeutics, Inc Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Aelis Farma SAS

      • 19.2.1 Aelis Farma SAS Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Confluence Pharmaceuticals LLC

      • 19.3.1 Confluence Pharmaceuticals LLC Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Neuren Pharmaceuticals Limited

      • 19.4.1 Neuren Pharmaceuticals Limited Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 F Hoffmann-La Roche Ltd

      • 19.5.1 F Hoffmann-La Roche Ltd Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Marinus Pharmaceuticals, Inc.

      • 19.6.1 Marinus Pharmaceuticals, Inc. Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Ovid Therapeutics Inc

      • 19.7.1 Ovid Therapeutics Inc Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 F. Hoffmann-La Roche Ltd.

      • 19.8.1 F. Hoffmann-La Roche Ltd. Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 MI.TO. Technology S.r.L.

      • 19.9.1 MI.TO. Technology S.r.L. Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Zynerba Pharmaceuticals, Inc.

      • 19.10.1 Zynerba Pharmaceuticals, Inc. Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 AMO Pharma Limited.

      • 19.11.1 AMO Pharma Limited. Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 MITO Technology SrL.

      • 19.12.1 MITO Technology SrL. Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    The List of Tables and Figures (Totals 104 Figures and 127 Tables)

    • Figure Product Picture

    • Figure Europe Fragile X Syndrome Market Size and Growth Rate of ACT-01 from 2014 to 2026

    • Figure Europe Fragile X Syndrome Market Size and Growth Rate of AMO-01 from 2014 to 2026

    • Figure Europe Fragile X Syndrome Market Size and Growth Rate of ANAVEX-273 from 2014 to 2026

    • Figure Europe Fragile X Syndrome Market Size and Growth Rate of AUT-00206 from 2014 to 2026

    • Figure Europe Fragile X Syndrome Market Size and Growth Rate of Bryostatin-1 from 2014 to 2026

    • Figure Europe Fragile X Syndrome Market Size and Growth Rate of Cannabidiol from 2014 to 2026

    • Figure Europe Fragile X Syndrome Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Europe Fragile X Syndrome Market Size and Growth Rate of Clinic from 2014 to 2026

    • Figure Europe Fragile X Syndrome Market Size and Growth Rate of Hopital from 2014 to 2026

    • Figure Europe Fragile X Syndrome Market Size and Growth Rate of Research Center from 2014 to 2026

    • Figure Germany Fragile X Syndrome Market Size and Growth Rate from 2014 to 2026

    • Figure UK Fragile X Syndrome Market Size and Growth Rate from 2014 to 2026

    • Figure France Fragile X Syndrome Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Fragile X Syndrome Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Fragile X Syndrome Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Fragile X Syndrome Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Fragile X Syndrome Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Fragile X Syndrome Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Fragile X Syndrome Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Fragile X Syndrome Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Fragile X Syndrome Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Fragile X Syndrome Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Fragile X Syndrome Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Fragile X Syndrome Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Fragile X Syndrome Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Fragile X Syndrome Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Fragile X Syndrome Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Fragile X Syndrome Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Fragile X Syndrome Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Fragile X Syndrome Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Fragile X Syndrome Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Fragile X Syndrome Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Fragile X Syndrome Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Fragile X Syndrome Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Fragile X Syndrome Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Fragile X Syndrome Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Fragile X Syndrome

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Fragile X Syndrome by Different Types from 2014 to 2026

    • Table Consumption Share of Fragile X Syndrome by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of ACT-01

    • Figure Market Size and Growth Rate of AMO-01

    • Figure Market Size and Growth Rate of ANAVEX-273

    • Figure Market Size and Growth Rate of AUT-00206

    • Figure Market Size and Growth Rate of Bryostatin-1

    • Figure Market Size and Growth Rate of Cannabidiol

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Fragile X Syndrome by Different End-Users from 2014 to 2026

    • Table Consumption Share of Fragile X Syndrome by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Clinic

    • Figure Market Size and Growth Rate of Hopital

    • Figure Market Size and Growth Rate of Research Center

    • Table Europe Fragile X Syndrome Production by Major Regions

    • Table Europe Fragile X Syndrome Production Share by Major Regions

    • Figure Europe Fragile X Syndrome Production Share by Major Countries and Regions in 2014

    • Table Europe Fragile X Syndrome Consumption by Major Regions

    • Table Europe Fragile X Syndrome Consumption Share by Major Regions

    • Table Germany Fragile X Syndrome Production, Import, Consumption and Export Analysis

    • Table UK Fragile X Syndrome Production, Import, Consumption and Export Analysis

    • Table France Fragile X Syndrome Production, Import, Consumption and Export Analysis

    • Table Italy Fragile X Syndrome Production, Import, Consumption and Export Analysis

    • Table Spain Fragile X Syndrome Production, Import, Consumption and Export Analysis

    • Table Poland Fragile X Syndrome Production, Import, Consumption and Export Analysis

    • Table Russia Fragile X Syndrome Production, Import, Consumption and Export Analysis

    • Table Switzerland Fragile X Syndrome Production, Import, Consumption and Export Analysis

    • Table Turkey Fragile X Syndrome Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Fragile X Syndrome Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Fragile X Syndrome Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Fragile X Syndrome Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Fragile X Syndrome Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Fragile X Syndrome Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Fragile X Syndrome Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Fragile X Syndrome Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Fragile X Syndrome Consumption by Types from 2014 to 2026

    • Table Germany Fragile X Syndrome Consumption Share by Types from 2014 to 2026

    • Table Germany Fragile X Syndrome Consumption by End-Users from 2014 to 2026

    • Table Germany Fragile X Syndrome Consumption Share by End-Users from 2014 to 2026

    • Table UK Fragile X Syndrome Consumption by Types from 2014 to 2026

    • Table UK Fragile X Syndrome Consumption Share by Types from 2014 to 2026

    • Table UK Fragile X Syndrome Consumption by End-Users from 2014 to 2026

    • Table UK Fragile X Syndrome Consumption Share by End-Users from 2014 to 2026

    • Table France Fragile X Syndrome Consumption by Types from 2014 to 2026

    • Table France Fragile X Syndrome Consumption Share by Types from 2014 to 2026

    • Table France Fragile X Syndrome Consumption by End-Users from 2014 to 2026

    • Table France Fragile X Syndrome Consumption Share by End-Users from 2014 to 2026

    • Table Italy Fragile X Syndrome Consumption by Types from 2014 to 2026

    • Table Italy Fragile X Syndrome Consumption Share by Types from 2014 to 2026

    • Table Italy Fragile X Syndrome Consumption by End-Users from 2014 to 2026

    • Table Italy Fragile X Syndrome Consumption Share by End-Users from 2014 to 2026

    • Table Spain Fragile X Syndrome Consumption by Types from 2014 to 2026

    • Table Spain Fragile X Syndrome Consumption Share by Types from 2014 to 2026

    • Table Spain Fragile X Syndrome Consumption by End-Users from 2014 to 2026

    • Table Spain Fragile X Syndrome Consumption Share by End-Users from 2014 to 2026

    • Table Poland Fragile X Syndrome Consumption by Types from 2014 to 2026

    • Table Poland Fragile X Syndrome Consumption Share by Types from 2014 to 2026

    • Table Poland Fragile X Syndrome Consumption by End-Users from 2014 to 2026

    • Table Poland Fragile X Syndrome Consumption Share by End-Users from 2014 to 2026

    • Table Russia Fragile X Syndrome Consumption by Types from 2014 to 2026

    • Table Russia Fragile X Syndrome Consumption Share by Types from 2014 to 2026

    • Table Russia Fragile X Syndrome Consumption by End-Users from 2014 to 2026

    • Table Russia Fragile X Syndrome Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Fragile X Syndrome Consumption by Types from 2014 to 2026

    • Table Switzerland Fragile X Syndrome Consumption Share by Types from 2014 to 2026

    • Table Switzerland Fragile X Syndrome Consumption by End-Users from 2014 to 2026

    • Table Switzerland Fragile X Syndrome Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Fragile X Syndrome Consumption by Types from 2014 to 2026

    • Table Turkey Fragile X Syndrome Consumption Share by Types from 2014 to 2026

    • Table Turkey Fragile X Syndrome Consumption by End-Users from 2014 to 2026

    • Table Turkey Fragile X Syndrome Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Fragile X Syndrome Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Fragile X Syndrome Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Fragile X Syndrome Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Fragile X Syndrome Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Fragile X Syndrome Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Fragile X Syndrome Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Fragile X Syndrome Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Fragile X Syndrome Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Fragile X Syndrome Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Fragile X Syndrome Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Fragile X Syndrome Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Fragile X Syndrome Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Fragile X Syndrome Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Fragile X Syndrome Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Fragile X Syndrome Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Fragile X Syndrome Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Fragile X Syndrome Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Fragile X Syndrome Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Fragile X Syndrome Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Fragile X Syndrome Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Fragile X Syndrome Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Fragile X Syndrome Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Fragile X Syndrome Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Fragile X Syndrome Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Fragile X Syndrome Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Fragile X Syndrome Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Fragile X Syndrome Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Fragile X Syndrome Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Fragile X Syndrome Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Sage Therapeutics, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sage Therapeutics, Inc

    • Figure Sales and Growth Rate Analysis of Sage Therapeutics, Inc

    • Figure Revenue and Market Share Analysis of Sage Therapeutics, Inc

    • Table Product and Service Introduction of Sage Therapeutics, Inc

    • Table Company Profile and Development Status of Aelis Farma SAS

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aelis Farma SAS

    • Figure Sales and Growth Rate Analysis of Aelis Farma SAS

    • Figure Revenue and Market Share Analysis of Aelis Farma SAS

    • Table Product and Service Introduction of Aelis Farma SAS

    • Table Company Profile and Development Status of Confluence Pharmaceuticals LLC

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Confluence Pharmaceuticals LLC

    • Figure Sales and Growth Rate Analysis of Confluence Pharmaceuticals LLC

    • Figure Revenue and Market Share Analysis of Confluence Pharmaceuticals LLC

    • Table Product and Service Introduction of Confluence Pharmaceuticals LLC

    • Table Company Profile and Development Status of Neuren Pharmaceuticals Limited

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Neuren Pharmaceuticals Limited

    • Figure Sales and Growth Rate Analysis of Neuren Pharmaceuticals Limited

    • Figure Revenue and Market Share Analysis of Neuren Pharmaceuticals Limited

    • Table Product and Service Introduction of Neuren Pharmaceuticals Limited

    • Table Company Profile and Development Status of F Hoffmann-La Roche Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of F Hoffmann-La Roche Ltd

    • Figure Sales and Growth Rate Analysis of F Hoffmann-La Roche Ltd

    • Figure Revenue and Market Share Analysis of F Hoffmann-La Roche Ltd

    • Table Product and Service Introduction of F Hoffmann-La Roche Ltd

    • Table Company Profile and Development Status of Marinus Pharmaceuticals, Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Marinus Pharmaceuticals, Inc.

    • Figure Sales and Growth Rate Analysis of Marinus Pharmaceuticals, Inc.

    • Figure Revenue and Market Share Analysis of Marinus Pharmaceuticals, Inc.

    • Table Product and Service Introduction of Marinus Pharmaceuticals, Inc.

    • Table Company Profile and Development Status of Ovid Therapeutics Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ovid Therapeutics Inc

    • Figure Sales and Growth Rate Analysis of Ovid Therapeutics Inc

    • Figure Revenue and Market Share Analysis of Ovid Therapeutics Inc

    • Table Product and Service Introduction of Ovid Therapeutics Inc

    • Table Company Profile and Development Status of F. Hoffmann-La Roche Ltd.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of F. Hoffmann-La Roche Ltd.

    • Figure Sales and Growth Rate Analysis of F. Hoffmann-La Roche Ltd.

    • Figure Revenue and Market Share Analysis of F. Hoffmann-La Roche Ltd.

    • Table Product and Service Introduction of F. Hoffmann-La Roche Ltd.

    • Table Company Profile and Development Status of MI.TO. Technology S.r.L.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of MI.TO. Technology S.r.L.

    • Figure Sales and Growth Rate Analysis of MI.TO. Technology S.r.L.

    • Figure Revenue and Market Share Analysis of MI.TO. Technology S.r.L.

    • Table Product and Service Introduction of MI.TO. Technology S.r.L.

    • Table Company Profile and Development Status of Zynerba Pharmaceuticals, Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Zynerba Pharmaceuticals, Inc.

    • Figure Sales and Growth Rate Analysis of Zynerba Pharmaceuticals, Inc.

    • Figure Revenue and Market Share Analysis of Zynerba Pharmaceuticals, Inc.

    • Table Product and Service Introduction of Zynerba Pharmaceuticals, Inc.

    • Table Company Profile and Development Status of AMO Pharma Limited.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AMO Pharma Limited.

    • Figure Sales and Growth Rate Analysis of AMO Pharma Limited.

    • Figure Revenue and Market Share Analysis of AMO Pharma Limited.

    • Table Product and Service Introduction of AMO Pharma Limited.

    • Table Company Profile and Development Status of MITO Technology SrL.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of MITO Technology SrL.

    • Figure Sales and Growth Rate Analysis of MITO Technology SrL.

    • Figure Revenue and Market Share Analysis of MITO Technology SrL.

    • Table Product and Service Introduction of MITO Technology SrL.

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US